|
CLN-978 Clinical Trials
3 actively recruiting trials across 2 locations
Pipeline
Phase 1: 3
Top Sponsors
- Cullinan Therapeutics Inc.3
Indications
- Arthritis2
- Sjogren Disease1
- Sjögren1
- SLE (Systemic Lupus)1
- SLE1
Other1 trial
Avondale, Arizona1 trial
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
Cullinan Investigative Site
Phase 1
Orlando, Florida1 trial
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease
Cullinan Investigative Site
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.